News
BIO
370.48
-4.02%
-15.52
Bio-Rad Laboratories' (NYSE:BIO) Solid Profits Have Weak Fundamentals
Simply Wall St · 23h ago
Bio-Rad Laboratories Earnings Call Signals Cautious Recovery
TipRanks · 1d ago
Bio Rad Laboratories (BIO) Stock Could Be 23% Overvalued Despite Activist Pressure
Simply Wall St · 2d ago
Why Bio-Rad (BIO) International Revenue Trends Deserve Your Attention
NASDAQ · 3d ago
Weekly Report: what happened at BIO last week (1102-1106)?
Weekly Report · 4d ago
Bio Rad Laboratories (BIO) Could Be 14% Overvalued After Elliott Interest And Earnings
Simply Wall St · 4d ago
Is Revenue Growth Return Altering The Investment Case For Bio Rad Laboratories (BIO)?
Simply Wall St · 5d ago
The Bio-Rad Laboratories, Inc. (NYSE:BIO) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
Simply Wall St · 6d ago
Bio-Rad Laboratories Price Target Raised to $440.00/Share From $390.00 by RBC Capital
Dow Jones · 11/05 18:51
Bio-Rad Laboratories Is Maintained at Outperform by RBC Capital
Dow Jones · 11/05 18:51
RBC Capital Maintains Outperform on Bio-Rad Laboratories, Raises Price Target to $440
Benzinga · 11/05 18:41
Bio-Rad (BIO) Q3 2026 Earnings Call Transcript
The Motley Fool · 11/05 15:45
Bio-Rad price target raised to $440 from $390 at RBC Capital
TipRanks · 11/05 15:11
Bio Rad Laboratories Climbed While Sales Fell
Simply Wall St · 11/05 12:31
What Bio-Rad Laboratories (BIO) Said on Its Q3 Earnings Call
NASDAQ · 11/05 09:14
Bio-Rad Reports Third-Quarter Results and Improved Profitability
TipRanks · 11/04 22:43
Bio-Rad Laboratories Q3 2026 Earnings Call Transcript
Benzinga · 11/04 22:38
Bio-Rad Laboratories Affirms FY2026 Sales Guidance of $2.506B-$2.596B vs $2.588B Est
Benzinga · 11/04 21:59
Bio-Rad Laboratories, Inc. GAAP EPS of $2.65, revenue of $656.4M beats by $6.45M
Seeking Alpha · 11/04 21:47
Bio-Rad reports Q3 adjusted EPS $2.65, consensus $2.23
TipRanks · 11/04 21:33
More
Webull provides a variety of real-time BIO stock news. You can receive the latest news about Bio Rad Labs Inc through multiple platforms. This information may help you make smarter investment decisions.
About BIO
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.